Biological responses to oxygen availability play important roles in development, physiological homeostasis, and many disease processes. In mammalian cells, this adaptation is mediated in part by a conserved pathway centered on the hypoxia-inducible factor (HIF). HIF is a heterodimeric protein complex composed of two members of the basic helix-loop-helix Per-ARNT-Sim (PAS) (ARNT, aryl hydrocarbon receptor nuclear translocator) domain family of transcriptional activators, HIF␣ and ARNT. Although this complex involves protein-protein interactions mediated by basic helixloop-helix and PAS domains in both proteins, the role played by the PAS domains is poorly understood. To address this issue, we have studied the structure and interactions of the C-terminal PAS domain of human HIF-2␣ by NMR spectroscopy. We demonstrate that HIF-2␣ PAS-B binds the analogous ARNT domain in vitro, showing that residues involved in this interaction are located on the solvent-exposed side of the HIF-2␣ central ␤-sheet. Mutating residues at this surface not only disrupts the interaction between isolated PAS domains in vitro but also interferes with the ability of full-length HIF to respond to hypoxia in living cells. Extending our findings to other PAS domains, we find that this ␤-sheet interface is widely used for both intra-and intermolecular interactions, suggesting a basis of specificity and regulation of many types of PAS-containing signaling proteins. C ellular responses to oxygen availability are essential for the development and homeostasis of mammalian cells, demonstrated most critically by the link between the cellular adaptation to reduced tissue oxygenation and disease progression (1, 2). In mammalian cells, these responses are mediated in part by the hypoxia-inducible factor (HIF), a heterodimeric transcription factor composed of HIF␣ and aryl hydrocarbon receptor nuclear translocator (ARNT, also known as HIF␤) (3). HIF activity is tightly controlled under normoxic conditions by multiple O 2 -dependent hydroxylation events of the HIF␣ subunit, which coordinately promote the ubiquitin-mediated destruction of this protein (4) and impair its ability to interact with transcriptional coactivators (5, 6) (Fig. 1a) . These controls are relieved during hypoxia, allowing HIF to activate the transcription of genes that facilitate metabolic adaptation to low oxygen levels and increase local oxygen supply by angiogenesis (7).
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All three isoforms of HIF␣ [HIF-1␣, -2␣ (EPAS1), and -3␣] (8, 9) and ARNT belong to the basic helix-loop-helix (bHLH)-Per-ARNT-Sim (PAS) family of eukaryotic transcription factors, which contain bHLH and PAS domains (Fig. 1) . The bHLH domains of these proteins serve as dimerization elements, helping determine the specificity of complex formation while providing a DNA-binding interface composed of the basic regions from each monomer (10) . PAS domains are widespread components of signal transduction proteins, currently identified in Ͼ2,000 proteins from organisms in all three kingdoms of life. These domains, shown to be protein-protein interaction elements in several systems (11) , also appear to contribute to the dimerization process and thus increase the specificity of bHLH-PAS transcription factor formation (12, 13) . In the case of the HIF␣͞ARNT complex, coimmunoprecipitation and gel mobility-shift experiments using truncated forms of HIF␣ and ARNT suggest that although the bHLH domains alone are able to dimerize, the PAS domains are required to build a stable heterodimer capable of robust DNA binding (14, 15) . These data suggest a model of the complex where the bHLH, PAS-A, and PAS-B domains of ARNT interact with their counterparts in HIF␣ (Fig. 1a) . However, most of this model remains speculative in light of the sparse data describing how PAS domains bind to each other, or more generally, to any protein partner.
To provide insight into this general topic of PAS domain signaling, particularly its importance in the hypoxia response pathway, we have studied the structure and interactions of the C-terminal PAS domain of human HIF-2␣ (HIF-2␣ PAS-B) by NMR spectroscopy. We report that HIF-2␣ PAS-B adopts a structure similar to other members of this family, with a central ␤-sheet flanked on one face by several ␣-helices. We further show that HIF-2␣ PAS-B binds directly to the human ARNT PAS-B domain in vitro, identifying the interface as a group of residues located in the central strands of the ␤-sheet. With structure-based mutations of this interface in the PAS-B domains of HIF-1␣ and -2␣, we demonstrate that such changes interfere with the binding of isolated PAS-B domains in vitro but more importantly disrupt the ability of full-length HIF proteins to respond to hypoxia in living cells. These observations led us to compare PAS domains from multiple systems, showing that the ␤-sheet interface participates in a wide range of inter-and intramolecular interactions and suggesting a way that specificity and regulation may be achieved among these versatile domains.
Materials and Methods
Protein Expression and Purification. DNA-encoding fragments of human HIF-2␣ PAS-B (residues 240-350) and ARNT PAS-B (residues 356-470) were subcloned into the pG␤1-parallel and pHis-parallel expression vectors, respectively (16, 17) . Escherichia coli BL21(DE3) cells transformed with these plasmids were grown in M9 media containing 1 g͞liter 15 NH 4 Cl for U- The purification of HIF-2␣ PAS-B has been detailed (18) . NMR samples typically contained 0.9 mM protein in 50 mM Tris buffer (pH 7.3), 15 mM NaCl, 5 mM DTT, 5 mM NaN 3 and a protease inhibitor mixture (Sigma) in 90% H 2 O͞10% D 2 O, unless otherwise noted. ARNT PAS-B was expressed and purified as described in Supporting Methods, which is published as supporting information on the PNAS web site.
Parallel studies on human HIF-1␣ PAS-B used a construct containing residues 238-349, chosen by homology with HIF-2␣ PAS-B. Expression and purification of HIF-1␣ PAS-B were done as described for HIF-2␣ PAS-B.
NMR Spectroscopy. All NMR data were recorded at 30°C with Varian Inova 500 and 600 MHz spectrometers by using NMRPIPE for data processing (19) and NMRVIEW for analysis (20) . Chemical-shift assignments were made by using standard methods (21) as detailed in Supporting Methods.
Deuterium exchange reactions were started by resuspending lyophilized Initial structures were determined without manual assignments by using ARIA1.2 (24, 25) and subsequently refined with a mix of automated and manual assignment of NOESY spectra. Of 1,000 structures, the 20 lowest-energy structures were analyzed with MOLMOL (26) and PROCHECK-NMR (27) .
From this ensemble, the structure closest to the mean was superimposed against other PAS domains with the DEEPVIEW Swiss Protein Data Bank program (28) with the automatic fit option. The calculated rms deviations ranged between 1.4 and 1.65 Å for HERG (Research Collaboratory for Structural Bioinformatics Protein Data Bank ID 1BYW), hPASK (1LL8), RmFixL (1D06), and Phy3 (1G28). The HIF-2␣ PAS-B structure was also used to generate a model of the HIF-1␣ PAS-B structure (74% sequence identity) by using MODELLER (29) .
HIF␣ and ARNT PAS-B Titration. Titrations were conducted by the stepwise addition of natural abundance ARNT PAS-B (up to 800 M) to a sample of 200-M HIF-2␣ at 35°C. The peak heights of HIF-2␣ PAS-B signals that do not show ARNT-dependent chemical shift changes (38 residues) were fit to Eq. 1 to obtain the corresponding K d :
where ⌬I is the observed change in peak height at ARNT concentration A, ⌬I max is the change in peak height at saturation, and P T is the total HIF␣ concentration. Eq. 1 is similar to the equation used to extract K d from chemical-shift changes observed in titrations of complexes undergoing fast exchange (30), and we apply it here only to sites without chemical-shift changes (fast exchange) to ensure that the observed peak line widths are a population-weighted average of the free-and bound-state line widths (31) . The binding of HIF-2␣ PAS-B mutants to ARNT PAS-B was assessed by adding 900 M natural abundant ARNT PAS-B to 250 M HIF␣ PAS B at 25°C.
Mutagenesis. Point mutants of full-length HIF-1␣ and -2␣ were created from wild-type DNA and primers including the desired mutation(s). PAS-B domains containing these mutations were obtained by PCR amplification of the corresponding full-length sequence and subcloned into the pG␤1-parallel vector. Transformation, protein induction, and purification were performed as described above.
Transfections. Cells were plated onto 48-well plates (3.5 ϫ 10 4 cells per well) in 200 l of HyQ DME͞F-12 1:1 media (HyClone) supplemented with 5% FBS 24 h before transfection. Cells were transfected with 10 ng of each HIF␣ construct and 20 ng of the 3HRE-tk-luc (HRE, hypoxia-responsive element) luciferase reporter construct (8) by using the Lipofectamine PLUS reagent (Invitrogen). After 3 h, the media were changed and, after an additional 2 h, cells were incubated for 15 h under normoxic or hypoxic (1.0% O 2 ) conditions. Luciferase activity was measured as described (32) .
Results

Solution Structure of HIF-2␣ PAS-B.
We determined the solution structure of HIF-2␣ PAS-B by using standard double-and triple-resonance NMR experiments conducted on uniformly 15 N and 15 N 13 C labeled protein samples (Fig. 2) . This structure is based on Ͼ2,500 geometric constraints obtained from measurements of interproton distances, dihedral angles, and 15 N-1 H residual dipolar couplings of a partially oriented sample ( Table  1 ). All of these data are well satisfied by the high-precision ensemble of the 20 lowest-energy structures subsequently used for further analysis.
HIF-2␣ PAS-B adopts a typical ␣͞␤ PAS domain fold, characterized by several ␣-helices flanking a five-stranded antiparallel ␤ sheet. The similarity of this structure to other PAS domains is demonstrated by the low-backbone rms deviation values (1.4-1.65 Å) of pairwise comparisons between representative PAS structures and HIF-2␣ PAS-B. Although several other PAS domains bind cofactors within their hydrophobic cores to regulate protein-protein interactions in response to various physical stimuli (11), a combination of NMR, mass spectrometry, and visible spectroscopy shows that HIF-2␣ PAS-B does not copurify with any such compound (data not shown). Further, no preformed cavities are present in the protein core, even at sites occupied by ligands in some other PAS domains (17, (33) (34) (35) (36) (Fig. 2b) .
Identification of ARNT PAS-B-Binding Surface on HIF-2␣ PAS-B.
The PAS domains in bHLH-PAS transcription factors are thought to cooperate with the bHLH domains to facilitate dimerization (12, 13) , which implies that the HIF␣ and ARNT PAS domains bind to each other (Fig. 1a) . To experimentally demonstrate this interaction, we titrated unlabeled ARNT PAS-B into (Fig. 3a) . Peaks in these spectra showed both chemical-shift changes and line broadening on addition of ARNT PAS-B, consistent with binding on the intermediate and fast exchange time scales. In contrast, we found that HIF-2␣ PAS-B signals were not affected by the addition of a PAS domain from PAS kinase, a protein not involved in the hypoxia response (17) (data not shown), suggesting that the changes observed on addition of ARNT PAS-B reflect a specific HIF-2␣͞ARNT interaction.
The ARNT-induced changes in the HIF-2␣ line widths demonstrate two important effects. First, we observed a general increase in line width for HIF-2␣ peaks during the titration, which we attribute to the slower tumbling of the larger 27-kDa heterodimeric complex compared with an isolated HIF-2␣ PAS-B domain. By monitoring this broadening via the decrease in peak heights as ARNT PAS-B was added, we observed a titration consistent with a 1:1 binding event with a 30 M K d (Fig.  3b) . This effect saturated at a 1:3 (HIF͞ARNT) ratio, establishing that it is not caused by nonspecific increases in sample viscosity or aggregation. Second, we observed that a subset of residues preferentially broadened on the addition of substoichiometric amounts of ARNT PAS-B. Such differential effects have been observed in several complexes (17, 37, 38) and arise from exchange broadening at sites experiencing significant chemical-shift changes on complex formation. Mapping sites that exhibit either this differential broadening or significant ARNT-induced chemical shift changes onto the HIF-2␣ PAS-B structure shows that they cluster on the face of the central ␤-sheet (Fig. 4) . This provides a chiefly hydrophobic surface for ARNT binding that is conserved among the HIF isoforms (Fig. 1) , suggesting that the PAS-B domains of all three interact similarly with ARNT.
Evidence for the importance of this interface in the HIF͞ARNT PAS-B dimer was obtained from studies of PAS-B domains containing point mutations. Based on our structure, we altered three residues with solvent-exposed side chains within the H␤ and I␤ strands (Q322E, M338E, and Y342T) (Fig. 4b) .
15
N͞ 1 H HSQC spectra of this triple mutant (trHIF-2␣ PAS-B) retain the chemicalshift dispersion and general pattern of the wild-type protein, confirming that the protein structure remains intact (Fig. 5a) . The ARNT-binding capability of this mutant was assessed by comparing 15 N͞ 1 H HSQC spectra before and after addition of unlabeled ARNT PAS-B. As demonstrated by the minimal ARNT-induced changes in peak locations and intensities, the interaction of the triple mutant HIF-2␣ PAS-B with ARNT has been very significantly weakened. These data establish that subtle changes on the surface of the H␤ and I␤ strands of HIF-2␣ PAS-B can disrupt the HIF-ARNT PAS-B interaction.
Comparison of HIF-1␣ and -2␣ PAS-B.
Sequence alignments of HIF-1␣ and -2␣ indicate that the PAS-B domains of these proteins are extremely similar (74% identity; Fig. 1b) . Nevertheless, the HIF-1␣ homolog of our HIF-2␣ PAS-B construct was too poorly behaved in solution to be amenable to structure determination. However, by combining the high sequence identity between these PAS-B domains and the HIF-2␣ PAS-B solution structure, we generated a homology model of HIF-1␣ PAS-B (29) . This guided our mutation of three solvent-exposed residues in the HIF-1␣ PAS-B ␤-sheet (Q320E͞V336E͞Y340T) at sites analogous to those changed in HIF-2␣ PAS-B. Interestingly, this HIF-1␣ PAS-B triple mutant was significantly better behaved in solution than the wild-type domain. To determine whether HIF-1␣ PAS-B bound ARNT PAS-B in a similar fashion as HIF-2␣ PAS-B, we recorded 15 N͞ 1 H HSQC of wild-type and triple-mutant HIF-1␣ PAS-B in the presence and absence of ARNT PAS-B (Fig. 7 , which is published as supporting information on the PNAS web site). In the case of wild-type HIF-1␣ PAS-B, the combination of specific peak shifting and line broadening on the addition of ARNT PAS-B indicated binding. In contrast, this interaction was disrupted in the triple mutant (Fig. 7) , demonstrating that the interface identified in HIF-2␣ is as crucial for the ARNT-binding function of HIF-1␣.
Functional Importance of PAS-B in Full-Length HIF␣. Our demonstration of specific interactions between the isolated HIF␣ and ARNT PAS-B domains suggested that they function as dimerization elements in the HIF heterodimer. To address this question in living cells with full-length HIF␣, we used a luciferasebased assay that uses Chinese hamster ovary (CHO) cells lacking functional HIF␣ (CHO-Ka13) (39) . CHO-Ka13 cells were transiently transfected with full-length HIF␣ constructs under the control of the HIF-1 promoter (40) and encoding either wildtype or a mutant sequence containing the three PAS-B domain mutations. Low levels of DNA were transfected to roughly match the HIF activity in wild-type CHO cells. The abilities of these HIF␣ constructs to activate transcription were determined by measuring the expression of luciferase under the control of a minimal HRE promoter (8) .
After expressing either wild-type HIF-1␣ or -2␣, the hypoxia response of the transfected CHO-Ka13 cells mimicked that of wild-type CHO cells, confirming that HIF␣ activity can be rescued by expression from these plasmids (Fig. 5b) . Cells transfected with HIF-2␣ constructs either lacking the entire PAS-B domain (⌬240-350) or containing a mutation known to unfold PAS-B (C339P; unfolded as established by NMR) showed no significant luciferase activity under any conditions (data not shown). Although these results suggest that HIF␣ PAS-B plays a crucial role in forming a biologically active HIF␣͞ARNT heterodimer, the question remained whether the subtler PAS-B modifications that disrupted in vitro binding would have a similar effect. Therefore, we transfected CHO-Ka13 cells with fulllength HIF-1␣ and -2␣ constructs containing the three PAS-B mutations (trHIF␣). For both mutant proteins, the HRE-driven luciferase response is decreased compared with that observed in cells containing vectors expressing wild-type HIF␣. In the case of trHIF-1␣, the response is virtually eliminated (Fig. 5b, column 3), whereas a less pronounced but significant reduction is observed for trHIF-2␣ (Fig. 5b, column 5) . These results are surprising in light of the three apparently redundant sets of protein-protein interactions implied by the model of the HIF heterodimer (Fig. 1a) . Our data show that the subtle disruption of the PAS-B interaction within the full length HIF␣ protein is sufficient to prevent the formation of the HIF transcription factor, thereby abolishing the hypoxia response.
Discussion
Despite the intense interest in hypoxia signaling, previous understanding of the roles of various protein-protein interactions in the HIF heterodimer remained unclear. Much of the data underlying prior work in this area were based on deletions generated at a time when the lack of structural data hampered the design of constructs cleanly corresponding to PAS domain boundaries. Unfortunately, this approach has complicated the interpretation of these findings with respect to the functional importance of individual PAS domains. In this context, our results provide the structural insight to clarify how PAS-B domains contribute to the stability of HIF and other bHLH-PAS transcription factor complexes. We demonstrate that the PAS-B domains of HIF␣ and ARNT directly associate in vitro, using a group of predominantly hydrophobic residues located on the solvent-exposed face of the HIF␣ ␤-sheet. Critically, mutations that disrupt the interaction between isolated PAS-B domains in vitro also interfere with the ability of the full-length heterodimer to activate transcription in living cells. These results establish the importance of the ␤-sheet interaction surface of HIF␣ PAS-B domains within the complexes that are central to the hypoxia response pathway.
More broadly, the ␤-sheet interface we identified appears to be important for a wide array of inter-and intramolecular interactions within several PAS domains (Fig. 6) . Evidence of this commonality is provided by PAS domains from two bluelight photoreceptors, phototropin1 (AsLOV2) (36) and photoactive yellow protein (33) . Both of these domains are flanked by additional ␣-helical elements that fold back on the PAS domain itself, associating with the same ␤-sheet region used by HIF␣ to bind ARNT (Fig. 6 ). An additional example is provided by the human ether-a-go-go-related gene (HERG) potassium channel, which contains a PAS domain that controls the poststimulation deactivation kinetics of this channel, possibly by interacting with Fig. 6 . Versatility of protein interactions involving PAS domain ␤-sheets. HIF2␣ is shown in the same orientation as Fig. 4b and colored by residues experiencing significant 15 N͞ 1 H chemical shifts on complex formation (red) and those used to generate the complex-disrupting trHIF-2␣ (blue). Phototropin (AsLOV2) (36) and photoactive yellow protein (33) highlight the ␣-helices external to the PAS core (magenta) and any atoms located within 5 Å of those helices (pink). HERG (42) shows functionally important, solvent-exposed residues (dark blue) and residues present in a surface hydrophobic patch suggested to be important for channel function (light blue) (42) .
the S4-S5 linker (41) . Point mutations in the PAS domain that impair channel function have been identified by both alanine scanning mutagenesis (42) and sequencing of HERG genes from individuals affected by long QT syndrome (41) , an inherited cardiac disorder associated with defects in HERG and other ion channels. Biochemical studies of channels containing one of several conservative mutations in solvent-exposed residues (F29L, F29A, N33T, Y43A, and R56Q; Fig. 6 ) demonstrate that the region analogous to the HIF͞ARNT interface plays an important role in regulating HERG channel kinetics. In summary, these comparisons indicate that the exposed face of the central ␤-sheet in PAS domains is well suited for making many functionally important types of associations.
This comparison also suggests a route that might be exploited to regulate the formation of the HIF␣-ARNT complex by using small organic compounds. Although neither a natural ligand nor a ligand-binding cavity has been identified for the HIF␣ PAS-B domains, this should not be interpreted to mean this domain cannot bind any small compounds. Indeed, it has been demonstrated that certain artificial chemicals can specifically bind into the well packed hydrophobic core of a PAS domain from PAS kinase (Fig. 2b) (17) , likely producing significant conformational changes therein. Parallel studies of two PAS domains with natural cofactors, AsLOV2 and photoactive yellow protein, have shown that relatively small structural changes in these internally bound compounds are sufficient to displace ␣-helices bound onto the same ␤-sheet interface we identified in HIF␣ (36, 43) . Combining these observations and an earlier model proposed for PAS domain signaling (44) raises the possibility that binding compounds in the HIF␣ PAS-B core could generate structural changes that disrupt the interactions needed to form the HIF heterodimer, analogous to the HIF␣ mutations demonstrated here. Given the central role of HIF in the hypoxia response and the importance of this pathway in cancer progression, this approach may serve as the basis for a novel therapeutic strategy (1, 2) .
